Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein
10.1038/nm0397-328
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Weidemann, A., Paliga, K., Dürrwang, U., Czech, C., Evin, G., Masters, C. L., & Beyreuther, K. (1997). Formation of stable complexes between two Alzheimer’s disease gene products: Presenilin-2 and β-amyloid precursor protein. Nature Medicine, 3(3), 328–332.

Authors 7
  1. A. Weidemann (first)
  2. K. Paliga (additional)
  3. U. Dürrwang (additional)
  4. C. Czech (additional)
  5. G. Evin (additional)
  6. C. L. Masters (additional)
  7. K. Beyreuther (additional)
References 36 Referenced 170
  1. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754–760 (1995). (10.1038/375754a0) / Nature by R Sherrington (1995)
  2. Rogaev, E.I. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775–778 (1995). (10.1038/376775a0) / Nature by EI Rogaev (1995)
  3. Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973–977 (1995). (10.1126/science.7638622) / Science by E Levy-Lahad (1995)
  4. Van Broeckhoven, C. Presenilins and Alzheimer disease. Nature Genet. 11, 230–232 (1995). (10.1038/ng1195-230) / Nature Genet. by C Van Broeckhoven (1995)
  5. Lemere, C.A. et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2, 1146–1150 (1996). (10.1038/nm1096-1146) / Nature Med. by CA Lemere (1996)
  6. Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736 (1987). (10.1038/325733a0) / Nature by J Kang (1987)
  7. Selkoe, D.J., β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271 18295–18298 (1996). (10.1074/jbc.271.31.18295) / J. Biol. Chem. by DJ Selkoe (1996)
  8. Weidemann, A. et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115–126 (1989). (10.1016/0092-8674(89)90177-3) / Cell by A Weidemann (1989)
  9. Esch, F.S. et al. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122–1124 (1990). (10.1126/science.2111583) / Science by FS Esch (1990)
  10. Haass, C. et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325 (1992). (10.1038/359322a0) / Nature by C Haass (1992)
  11. Shoji, M. et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258, 126–129 (1992). (10.1126/science.1439760) / Science by M Shoji (1992)
  12. Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336–1340 (1994). (10.1126/science.8191290) / Science by N Suzuki (1994)
  13. Jarrett, J.T., Berger, E.P. & Lansbury, P.T. Jr., The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693–4697 (1993). (10.1021/bi00069a001) / Biochemistry by JT Jarrett (1993)
  14. Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672–674 (1992). (10.1038/360672a0) / Nature by M Citron (1992)
  15. Cai, X.D., Golde, T.E. & Younkin, S.G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514–516 (1993). (10.1126/science.8424174) / Science by XD Cai (1993)
  16. Haass, C., Hung, A.Y., Selkoe, D. & Teplow, D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 17741–17748 (1994). (10.1016/S0021-9258(17)32503-6) / J. Biol. Chem. by C Haass (1994)
  17. Kovacs, D.M. et al. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intra cellular membranes in mammalian cells. Nature Med. 2, 224–229 (1996). (10.1038/nm0296-224) / Nature Med. by DM Kovacs (1996)
  18. Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaque of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996). (10.1038/nm0896-864) / Nature Med. by D Scheuner (1996)
  19. Duff, K. et al. Increased amyloid-b42 (43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713 (1996). (10.1038/383710a0) / Nature by K Duff (1996)
  20. Thinakaran, G. et al. Endoproteoysis of presenilin 1 and acumulation of processed derivatives in vivo. Neuron 17, 1–20 (1996). (10.1016/S0896-6273(00)80291-3) / Neuron by G Thinakaran (1996)
  21. Mercken, M. et al. Characterisation of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389, 297–303 (1996). (10.1016/0014-5793(96)00608-4) / FEBS Lett. by M Mercken (1996)
  22. Kim, T.W., Hallmark, O.G., Pettingell, W., Wasco, W. & Tanzi, R.E. Proteolytic processing of wild-type and mutant forms of presenilin 2. Neurobiol. Aging 17, 155–159 (1996). (10.1016/S0197-4580(96)80626-9) / Neurobiol. Aging by TW Kim (1996)
  23. Podlisny, M.B., Tolan, D.R. & Selkoe, D.J. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Pathol. 138, 1423–1435 (1991). / Am. J. Pathol. by MB Podlisny (1991)
  24. König, G. et al. Identification and differential expression of a novel alternative splice isoform of the βA4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J. Biol. Chem. 267, 10804–10809 (1992). (10.1016/S0021-9258(19)50090-4) / J. Biol. Chem. by G König (1992)
  25. Wasco, W. et al. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc. Natl. Acad. Sci. USA 89, 10758–10762 (1992). (10.1073/pnas.89.22.10758) / Proc. Natl. Acad. Sci. USA by W Wasco (1992)
  26. High, S. et al. Sec61p is adjacent to nascent type 1 and type II signal-anchor proteins during their membrane insertion. J. Cell Biol. 121, 743–750 (1993). (10.1083/jcb.121.4.743) / J. Cell Biol. by S High (1993)
  27. Simons, M.T. et al. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899–908 (1996). (10.1523/JNEUROSCI.16-03-00899.1996) / J. Neurosci. by MT Simons (1996)
  28. Hammond, C. & Helenius, A. Quality control in the secretory pathway: Retention of misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J. Cell Biol. 126, 41 52 (1994). (10.1083/jcb.126.1.41) / J. Cell Biol. by C Hammond (1994)
  29. Haass, C. & Selkoe, D.J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75, 1039–1042 (1993). (10.1016/0092-8674(93)90312-E) / Cell by C Haass (1993)
  30. Kuentzel, S.L. et al. The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295, 367–378 (1993). (10.1042/bj2950367) / Biochem. J. by SL Kuentzel (1993)
  31. Citron, M. et al. Inhibition of amyloid β-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron 17, 171–179 (1996). (10.1016/S0896-6273(00)80290-1) / Neuron by M Citron (1996)
  32. Zhong, Z., Quon, D., Higgins, L.S., Higaki, J. & Cordell, B. Increased amyloid production from aberrant beta-amyloid precursor proteins. J. Biol. Chem. 269, 12179–12184 (1994). (10.1016/S0021-9258(17)32698-4) / J. Biol. Chem. by Z Zhong (1994)
  33. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β–amyloid precursor protein. Nature 373, 523–527 (1995). (10.1038/373523a0) / Nature by D Games (1995)
  34. Knop, M., Finger, A., Braun, T., Hellmuth, K. & Wolf, D.H., Der1 a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J. 15, 753–763 (1996). (10.1002/j.1460-2075.1996.tb00411.x) / EMBO J. by M Knop (1996)
  35. Kunkel, T.A., Roberts, J.D. & Zakour, R.A. Rapid and efficient site specific mutagenesis without phenotypic selection. Meth. Enzym. 154, 367–382 (1987). (10.1016/0076-6879(87)54085-X) / Meth. Enzym. by TA Kunkel (1987)
  36. Dyrks, T. et al. Generation of beta A4 from the amyloid protein precursor and fragments thereof. FEBS Lett. 335, 89–93 (1993). (10.1016/0014-5793(93)80446-2) / FEBS Lett. by T Dyrks (1993)
Dates
Type When
Created 21 years ago (Aug. 18, 2004, 9:46 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:11 p.m.)
Indexed 11 months, 2 weeks ago (Sept. 8, 2024, 5:38 a.m.)
Issued 28 years, 5 months ago (March 1, 1997)
Published 28 years, 5 months ago (March 1, 1997)
Published Print 28 years, 5 months ago (March 1, 1997)
Funders 0

None

@article{Weidemann_1997, title={Formation of stable complexes between two Alzheimer’s disease gene products: Presenilin-2 and β-amyloid precursor protein}, volume={3}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm0397-328}, DOI={10.1038/nm0397-328}, number={3}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Weidemann, A. and Paliga, K. and Dürrwang, U. and Czech, C. and Evin, G. and Masters, C. L. and Beyreuther, K.}, year={1997}, month=mar, pages={328–332} }